ABSTRACT
Fact Sheet for Healthcare Providers: Beckman Coulter, Inc., Access SARS‐CoV‐2 IgM [open pdf - 173KB]
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Access SARS‐CoV‐2 [severe acute respiratory syndrome coronavirus 2] IgM [Immunoglobulin M]. [...] The Access SARS‐CoV‐2 IgM is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma."
| Publisher: | |
| Date: | 2020-10-08 |
| Series: | |
| Copyright: | Public Domain |
| Retrieved From: | U.S. Food and Drug Administration: https://www.fda.gov/ |
| Format: | pdf |
| Media Type: | application/pdf |
| URL: |